HealthDay – MONDAY, May 25 (HealthDay News) — The use of the drug bevacizumab
(Avastin) in combination with chemotherapy greatly increases the risk of
gastrointestinal perforations in cancer patients, new research has
found.
Read more
law clerks
candida diet

Related posts:

1. Cancer Drug May Boost Risk of Gastrointestinal Perforation (HealthDay) HealthDay - MONDAY, May 25 (HealthDay News) -- The use...
2. Cancer Drug May Boost Risk of Gastrointestinal Perforation (HealthDay) HealthDay - MONDAY, May 25 (HealthDay News) -- The use...
3. Broad-Spectrum Cervical Cancer Vaccine Shows Promise (HealthDay) HealthDay - TUESDAY, May 26 (HealthDay News) -- An investigational...
4. Broad-Spectrum Cervical Cancer Vaccine Shows Promise (HealthDay) HealthDay - TUESDAY, May 26 (HealthDay News) -- An investigational...
5. Simple Test Could Detect More Gastrointestinal Cancers (HealthDay) HealthDay - TUESDAY, June 2 (HealthDay News) -- DNA testing...

Related posts brought to you by Yet Another Related Posts Plugin.

This entry was posted on Sunday, June 7th, 2009 at 12:20 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.